143 related articles for article (PubMed ID: 35180865)
1. NCAPG promotes the oncogenesis and progression of non-small cell lung cancer cells through upregulating LGALS1 expression.
Sun H; Zhang H; Yan Y; Li Y; Che G; Zhou C; Nicot C; Ma H
Mol Cancer; 2022 Feb; 21(1):55. PubMed ID: 35180865
[TBL] [Abstract][Full Text] [Related]
2. Galectin-1-mediated high NCAPG expression correlates with poor prognosis in gastric cancer.
Zheng T; Qian T; Zhou H; Cheng Z; Liu G; Huang C; Dou R; Liu F; You X
Aging (Albany NY); 2023 Jun; 15(12):5535-5549. PubMed ID: 37335105
[TBL] [Abstract][Full Text] [Related]
3. Non-SMC Condensin I Complex, Subunit G (NCAPG) is a Novel Mitotic Gene Required for Hepatocellular Cancer Cell Proliferation and Migration.
Zhang Q; Su R; Shan C; Gao C; Wu P
Oncol Res; 2018 Mar; 26(2):269-276. PubMed ID: 29046167
[TBL] [Abstract][Full Text] [Related]
4. PRDX2 Promotes the Proliferation and Metastasis of Non-Small Cell Lung Cancer
Chen Y; Yang S; Zhou H; Su D
Biomed Res Int; 2020; 2020():8359860. PubMed ID: 32908916
[TBL] [Abstract][Full Text] [Related]
5. ILT4 inhibition prevents TAM- and dysfunctional T cell-mediated immunosuppression and enhances the efficacy of anti-PD-L1 therapy in NSCLC with EGFR activation.
Chen X; Gao A; Zhang F; Yang Z; Wang S; Fang Y; Li J; Wang J; Shi W; Wang L; Zheng Y; Sun Y
Theranostics; 2021; 11(7):3392-3416. PubMed ID: 33537094
[No Abstract] [Full Text] [Related]
6. B-Myb Mediates Proliferation and Migration of Non-Small-Cell Lung Cancer via Suppressing IGFBP3.
Fan X; Wang Y; Jiang T; Cai W; Jin Y; Niu Y; Zhu H; Bu Y
Int J Mol Sci; 2018 May; 19(5):. PubMed ID: 29772705
[TBL] [Abstract][Full Text] [Related]
7. Galectin-1 promotes lung cancer progression and chemoresistance by upregulating p38 MAPK, ERK, and cyclooxygenase-2.
Chung LY; Tang SJ; Sun GH; Chou TY; Yeh TS; Yu SL; Sun KH
Clin Cancer Res; 2012 Aug; 18(15):4037-47. PubMed ID: 22696230
[TBL] [Abstract][Full Text] [Related]
8. NT5DC2 suppression restrains progression towards metastasis of non-small-cell lung cancer through regulation p53 signaling.
Jin X; Liu X; Zhang Z; Xu L
Biochem Biophys Res Commun; 2020 Dec; 533(3):354-361. PubMed ID: 32962856
[TBL] [Abstract][Full Text] [Related]
9. B-Myb Is Up-Regulated and Promotes Cell Growth and Motility in Non-Small Cell Lung Cancer.
Jin Y; Zhu H; Cai W; Fan X; Wang Y; Niu Y; Song F; Bu Y
Int J Mol Sci; 2017 May; 18(6):. PubMed ID: 28555007
[TBL] [Abstract][Full Text] [Related]
10. Knockdown of LncRNA PVT1 inhibits tumorigenesis in non-small-cell lung cancer by regulating miR-497 expression.
Guo D; Wang Y; Ren K; Han X
Exp Cell Res; 2018 Jan; 362(1):172-179. PubMed ID: 29133127
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of NCAPG in ovarian cancer is associated with ovarian cancer proliferation and apoptosis via p38 MAPK signaling pathway.
Yu H; Zou D; Ni N; Zhang S; Zhang Q; Yang L
J Ovarian Res; 2022 Aug; 15(1):98. PubMed ID: 35986371
[TBL] [Abstract][Full Text] [Related]
12. Knockdown of lncRNA DLX6-AS1 inhibits cell proliferation, migration and invasion while promotes apoptosis by downregulating PRR11 expression and upregulating miR-144 in non-small cell lung cancer.
Huang Y; Ni R; Wang J; Liu Y
Biomed Pharmacother; 2019 Jan; 109():1851-1859. PubMed ID: 30551440
[TBL] [Abstract][Full Text] [Related]
13. NCAPG deregulation indicates poor patient survival and contributes to colorectal carcinogenesis.
Sun DP; Wu CC; Chou CL; Cheng LC; Wang WC; Lin SS; Hung ST; Tian YF; Fang CL; Lin KY
Pathol Res Pract; 2023 Jan; 241():154238. PubMed ID: 36442414
[TBL] [Abstract][Full Text] [Related]
14. MiR-25 is up-regulated in non-small cell lung cancer and promotes cell proliferation and motility by targeting FBXW7.
Xiang J; Hang JB; Che JM; Li HC
Int J Clin Exp Pathol; 2015; 8(8):9147-53. PubMed ID: 26464659
[TBL] [Abstract][Full Text] [Related]
15. SMYD3 overexpression indicates poor prognosis and promotes cell proliferation, migration and invasion in non‑small cell lung cancer.
Li J; Zhao L; Pan Y; Ma X; Liu L; Wang W; You W
Int J Oncol; 2020 Sep; 57(3):756-766. PubMed ID: 32705243
[TBL] [Abstract][Full Text] [Related]
16. Proliferating cell nuclear antigen promotes cell proliferation and tumorigenesis by up-regulating STAT3 in non-small cell lung cancer.
Wang L; Kong W; Liu B; Zhang X
Biomed Pharmacother; 2018 Aug; 104():595-602. PubMed ID: 29803172
[TBL] [Abstract][Full Text] [Related]
17. Nonstructural maintenance of chromatin condensin I complex subunit G promotes the progression of glioblastoma by facilitating Poly (ADP-ribose) polymerase 1-mediated E2F1 transactivation.
Hou J; Huang P; Xu M; Wang H; Shao Y; Weng X; Liu Y; Chang H; Zhang L; Cui H
Neuro Oncol; 2023 Nov; 25(11):2015-2027. PubMed ID: 37422706
[TBL] [Abstract][Full Text] [Related]
18. RNA sequencing reveals the transcriptomic landscape and alternative splicing events induced by LGALS1 silencing in non-small cell lung cancer.
Shi H; Zhang Y; Liu J; Wang Y; Fang P
Adv Clin Exp Med; 2024 Jan; 33(1):79-90. PubMed ID: 37341175
[TBL] [Abstract][Full Text] [Related]
19. NCAPG promotes tumorigenesis of bladder cancer through NF-κB signaling pathway.
Tang F; Yu H; Wang X; Shi J; Chen Z; Wang H; Wan Z; Fu Q; Hu X; Zuhaer Y; Liu T; Yang Z; Peng J
Biochem Biophys Res Commun; 2022 Sep; 622():101-107. PubMed ID: 35843088
[TBL] [Abstract][Full Text] [Related]
20. Increased expression of NCAPG (Non-SMC condensing I complex subunit G) is associated with progression and poor prognosis of lung adenocarcinoma.
Wang X; Tian X; Sui X; Li X; Zhao X; Han K; Sun L; Dong Y
Bioengineered; 2022 Mar; 13(3):6113-6125. PubMed ID: 35254214
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
